MARKET

CPHRF

CPHRF

Cipher Phrmctcls
OTCQX
11.94
+0.36
+3.11%
Closed 12:13 07/06 EDT
OPEN
11.95
PREV CLOSE
11.58
HIGH
11.95
LOW
11.86
VOLUME
500
TURNOVER
5.96K
52 WEEK HIGH
15.00
52 WEEK LOW
8.73
MARKET CAP
303.37M
P/E (TTM)
10.03
1D
5D
1M
3M
1Y
5Y
1D
Cipher Pharma signs pCPA letter of intent for Canada public drug plan coverage of Epuris
PUBT · 13h ago
CIPHER PHARMACEUTICALS AND THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA) SIGN LETTER OF INTENT FOR PUBLIC DRUG PLAN COVERAGE OF EPURIS®
Reuters · 14h ago
Weekly Report: what happened at CPHRF last week (0629-0703)?
Weekly Report · 1d ago
Weekly Report: what happened at CPHRF last week (0622-0626)?
Weekly Report · 06/29 09:25
Weekly Report: what happened at CPHRF last week (0615-0619)?
Weekly Report · 06/22 09:29
Cipher Pharma shareholders approve director slate at annual meeting
PUBT · 06/18 17:19
Weekly Report: what happened at CPHRF last week (0608-0612)?
Weekly Report · 06/15 09:29
Weekly Report: what happened at CPHRF last week (0601-0605)?
Weekly Report · 06/08 09:27
More
About CPHRF
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products, manages the required clinical development and regulatory approval process, and markets those products either directly or indirectly in Canada, the United States and South America. The Company's product categories include dermatology, hospital acute care, out‑licensed, and specialty medicine. Its dermatology products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Absorica (isotretinoin) is an oral retinoid. Durela, its specialty medicine, is an opioid analgesic indicated for the management of moderate to moderately severe pain in adults who require continuous treatment for several days or more. Its pipeline products include Piclidenoson CF-101, MOB-015 and DTR-001.

Webull offers Cipher Pharmaceuticals Inc stock information, including OTCQX: CPHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPHRF stock methods without spending real money on the virtual paper trading platform.